PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pfizer

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

July 1, 2022

Disease of the Month: Vitiligo Disease | PharmaShots

Disease of the Month: Vitiligo Disease | PharmaShots

June 25, 2022

Pfizer Reports Updated Results of Paxlovid (nirmatrelvir and ritonavir) in the P-II/III (EPIC-SR) Trial for the Treatment of COVID-19

Pfizer Reports Updated Results of Paxlovid (nirmatrelvir and ritonavir) in the P-II/III (EPIC-SR) Trial for the Treatment of COVID...

June 15, 2022

Pfizer’s Ervogastat + Clesacostat Receives the US FDA’s Fast Track Designation for the Treatment of Non-Alcoholic Steatohepatitis

Pfizer’s Ervogastat + Clesacostat Receives the US FDA’s Fast Track Designation for the Treatment of Non-Alcoholic Steatohepatitis

May 27, 2022

Pfizer and BioNTech Report EUA Expansion for Booster Dose of COVID-19 Vaccine in Children Aged 5 Through 11 Years

Pfizer and BioNTech Report EUA Expansion for Booster Dose of COVID-19 Vaccine in Children Aged 5 Through 11 Years

May 18, 2022

Pfizer Files Lawsuit to Halt Sales of Brenzys (biosimilar, etanercept) in Australia

Pfizer Files Lawsuit to Halt Sales of Brenzys (biosimilar, etanercept) in Australia

May 16, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us